The Venture Codex Logo

The Venture Codex

TPG ART

345 California Street, Suite 3300, San Francisco, CA, 94104, United States

Overview

TPG is a global alternative asset manager that focuses on innovation. It manages a portfolio of active companies in various countries. It serves technology, healthcare, and impact investing industries.

Total investments
7
Lead investments
5
Investments · 12mo
0
Active investors
0

Sector focus

  • Asset Management
  • Digital Media
  • Financial Services
  • Real Estate Investment
  • Renewable Energy
Visit website

Investment portfolio

  • Anuvia Plant Nutrients

    Participated · Equity · Feb 2021

    Anuvia Plant Nutrients develops and manufactures sustainable field-ready bio-based fertilizers, including its SymTRX XP line, for agriculture, turf, and lawncare. The company uses proprietary technology to optimize nutrient availability and efficiency for plants while improving soil health, preserving natural resources, and reducing greenhouse gas emissions. Led by CEO Amy Yoder, Anuvia produces fertilizers at a U.S.-based eco-friendly manufacturing facility and recently completed an expansion of its Plant City, Florida plant. The Plant City facility has capacity to expand to 1.2 million tons per year, which the company says could service over 20 million acres of agricultural crops. Anuvia intends to increase production capacity further and expand commercialization of its SymTRX XP products to meet growing demand for sustainable fertilizers. Anuvia Plant Nutrients converts excrement, food waste and agricultural processing waste into controlled-release fertilizers using a proprietary catalytic process. Its treatment controls nutrient release to boost crop productivity, reduces leaching to protect groundwater, and returns carbon to the soil. The technology is already used on roughly 1,200 farms and the company projects deployment on 20 million acres by 2025; ERM verified its performance versus traditional fertilizer on corn, rice and cotton. Anuvia says farmers see increased yields around five times their previous production levels, and that its treatment can cut production greenhouse-gas emissions by up to 32% compared with commercial fertilizers. The company operates a 1.2 million-ton production facility and plans to build additional capacity and develop new fertilizers for market. Anuvia is led by Amy Yoder and is backed by investors including TPG ART, Pontifax Global Food and Agriculture Technology Fund, Generate Capital and Piva Capital. Anuvia Plant Nutrients develops enhanced-efficiency fertilizers using a patented process that converts organic waste into a homogenous multi-nutrient product for turf and agricultural customers. The company's core product is a specialty enhanced-efficiency fertilizer (EEF) serving agricultural, professional turf and consumer lawn care markets. Management is led by CEO Amy Yoder. Anuvia opened its specialty fertilizer production facility in Zellwood, Fla. in April 2016, which is expected to produce 80,000 tons annually. The company recently secured $23M in equity funding to support product development and expansion. Planned uses include developing a liquid formulation, expanding into international markets, and building a second plant in Zellwood to enable further growth.

  • Anuvia

    Led · Series C · Feb 2021

    Anuvia produces SymTRX, a plug-and-play bio-fertilizer sold commercially in the U.S. that works with farmers' existing equipment for crops including corn, soybeans, wheat, canola, sugar beans, and sugar beets. The product is made by breaking down waste materials into an organic matrix that adds charged nutrients and mimics natural soil formation, which Anuvia says boosts crop yields and can increase farmer ROI up to five times. Anuvia retained Environmental Resources Management (ERM) to measure SymTRX performance; ERM concluded the product reduces greenhouse-gas production by up to 32% versus conventional fertilizer and found that every one million acres using it removes emissions equivalent to up to 30,000 vehicles. The company says SymTRX is competitively priced with roughly a $5 per acre premium and anticipates commercial usage to reach 20 million acres by 2025. Anuvia distributes primarily through existing ag retail channels and works directly with farmers on education, emphasizing product performance and soil-health benefits. It recently reached an exclusive U.S. license with The Mosaic Company to sell SymTRX as Susterra and plans to expand production capacity with a new commercial facility in Plant City, Florida.

  • Concentric Agriculture

    Participated · Series B · Apr 2018

    Inocucor develops and sells biological crop stimulants using a patented fermentation process, with two commercial products: Synergro (a live-cell formulation for high-value produce) and Synergro Free (a cell-free bio-fertilizer for commodity row crops). The Montreal-headquartered company combines multi-strain bacteria and yeasts into products intended to boost plant growth via metabolic signals rather than live microbes. Inocucor is pursuing geographic expansion in Brazil, Argentina, Uruguay and Western Europe (notably Spain) and is opening a Denver office to expand U.S. reach. The company has begun executing an acquisition-led growth strategy and completed its first acquisition of ATP Nutrition to combine R&D and distribution capabilities. Inocucor plans to create product combinations of biologicals and crop nutrition tailored by plant type, geography and soil conditions to improve efficacy. Financially, Inocucor closed a final Series B on $54.4 million and its commercialized products and grower sales were cited by investors as differentiators in the biologicals space. Inocucor develops and produces biological crop inputs for high-value produce and row crops, using a patented fermentation process to combine multi-strains of bacteria, yeasts and fungi into biostimulants. Its first- and second-generation products, Synergro® and Synergro Free™, are designed to improve yields, shorten growing periods and create resilient soils for farmers and greenhouse growers. The company is also advancing a suite of microbial biocontrol products targeting economically devastating diseases in potatoes, tomatoes and strawberries. Proceeds from the Series B will be used to accelerate commercialization through increased production and marketing of current products and to advance biocontrol development. Inocucor operates an R&D-focused Technical Center of Excellence in Montreal that is being expanded from 10,000 to 20,000 square feet and is constructing a 30,000-square-foot U.S. headquarters and commercialization office in Centennial, Colorado. The company employs about 40 people across Montreal and the U.S. and anticipates adding another 25–30 high-level scientific and managerial professionals over the next year. The company is led by President and CEO Donald R. Marvin. Inocucor Technologies develops sustainable biological crop inputs using a patented fermentation process that combines multi-strains of bacteria and yeasts into soil and plant optimizers. Its flagship live-cell product, Garden Solution®, will be rebranded in the U.S. as Synergro™, and the company also offers Synergro Free™, a cell-free bio-fertilizer additive for commodity row crops. The product pipeline includes bio-control formulations targeting diseases in high-value crops such as strawberries, tomatoes and potatoes. Inocucor is starting internal and external field trials for the 2017 growing season based on prior row-crop trial data from commercial partners in Latin America and North America. The company plans to use new funding to open a U.S. headquarters and commercialization office, increase manufacturing capacity at its Montreal pilot production and R&D facility, and add managerial and scientific staff. The company is led by President and CEO Donald R. Marvin. Inocucor Technologies develops sustainable microbial crop accelerators, with its flagship product Garden Solution produced through fermentation akin to winemaking to boost soil microbial diversity and nutrient delivery. Garden Solution is approved for sale in 27 U.S. states and is in use by farmers and greenhouse growers in North Carolina, South Carolina, Florida, Georgia and Virginia. The company is led by president and CEO Donald R. Marvin. Inocucor’s growth strategy emphasizes establishing commercial partnerships and making strategic acquisitions to commercialize its proprietary microbial consortia technology and broaden its product pipeline. The company plans to expand large-scale field trials and commercialization activities in North and South America for second- and third-generation cell-free biological formulations, proprietary new biological entities and active compounds for bio-fertility and bio-protection. Financially, Inocucor recently raised additional capital via an extended Series A to support scale-up of its Garden Solution. Inocucor Technologies develops patented fermentation-based solutions and live-microbe products aimed at improving seed germination and increasing crop yields. Its first product, Garden Solution, employs live microbes to improve the phyto-microbiome and plant health. The company uses a fermentation process described as similar to winemaking to produce its solutions. Inocucor is launching a second-generation cell-free bio-stimulation product targeting the production agriculture market and plans to accelerate its commercialization. Management says proceeds from financing will be used to further commercialize its patented technology and may be used to acquire complementary technologies and products currently under review. The company is led by president and CEO Donald R. Marvin.

  • Mercatus

    Led · Series B · Feb 2017

    Mercatus offers a cloud-based Energy Investment Lifecycle Management (ILM) platform that automates the full asset investment lifecycle from origination through end-of-life. The platform serves renewable energy developers and asset owners and is used by some of the largest energy companies. Customers collectively leverage the ILM platform to manage over 100 GW of projects across 75 countries using eight advanced energy technologies. The company plans to use the new funding to launch an Asset Management Solution targeted for April and to accelerate its product roadmap toward a digital utility workforce vision. Mercatus also intends to expand further into international markets, particularly South America, Southeast Asia, India, China, and Japan. Mercatus provides cloud-based energy investment management software that helps global energy producers gain insight and increase compliance of their advanced energy portfolios. The platform is used by large energy companies to host over 80GW of power across 75 countries. Supported technologies on the platform include solar, wind, biomass, storage, small hydro, energy efficiency, CHP, and geothermal. Led by CEO Haresh Patel, the company plans to use the new funding to expand operations. Mercatus is positioned to serve large-scale energy portfolios with a compliance and analytics focus. Mercatus, founded in 2009 as SCS Renewables and based in Santa Clara, Calif., provides software solutions for the energy finance industry. Its platform has enabled roughly $250 million in investments and transactions and currently serves more than 40% of the U.S. commercial and utility solar markets. The company recently introduced an energy-industry credit score calculated from eight criteria to create an economic and risk profile for projects. Developers can submit a project and receive a score within 48 hours; scores are visible to both developers and institutional investors. Mercatus aims to increase developers’ understanding of what makes a project fundable and to open the industry to sources of finance beyond angels and venture capitalists. The company raised more than $2 million in its first institutional funding round to support the credit-score rollout.

  • VitAG

    Led · Equity · Jul 2014

    VitAg Corporation converts municipal biosolids into inorganic fertilizers using its VitAg recycling technology. The company produces slow-release, organically-enhanced premium granular fertilizer by combining biosolids, sulfuric acid and ammonia via a proprietary process. VitAg expects its product to be considered an enhanced efficiency fertilizer with a significant portion of nutrients released over an extended period and to meet US EPA Class A and EQ standards for land application of biosolids. The company plans to use the new capital to construct a biosolids-to-fertilizer facility near Zellwood, Florida; CDM Constructors will build the facility and A. J. Sackett will design and fabricate granulation and storage equipment. Trammo, Inc. has entered a multi-year marketing agreement to sell VitAg’s fertilizer. VitAg is based in Beech Island, South Carolina and will sell through distributors in the United States and internationally.

Team

No current team members are available.